Results 21 to 30 of about 79,526,962 (296)
Interleukin-5 and Interleukin-5 Receptor Polymorphism in Asthma
, 2023 Asthma is a common chronic inflammatory disease of the airways of the lungs, in the world. It’s associated with type 2 cytokines interleukin-4, IL-5, and IL-13, which promote airway eosinophilia, bronchial hyperresponsiveness, mucus overproduction, and immunogloubulin E synthesis.
Raghdah Maytham Hameed +2 more
openaire +1 more source
Memorias do Instituto Oswaldo Cruz, 1997 In many helminth infected hosts the number of eosinophils increases dramatically, often without any concurrent increases in the number of other leukocytes, so that eosinophils become the dominant cell type.
Karen S Ovington, Carolyn A Behm
doaj +1 more source
Optimization of Interleukin-5 Protein Expression in BL21 Strain of Escherichia Coli
مجله دانشکده پزشکی اصفهان, 2020 Background: In asthma, the relationship between number of eosinophils and severity of this disease supports the hypothesis that eosinophil is the major effector cell in inflammation of airway. Evolution of eosinophils is regulated by interlukin-5 (IL-5).
mina Jamalvandi +3 more
doaj +1 more source
Memorias do Instituto Oswaldo Cruz, 1997 Clinical and experimental investigations suggest that allergen-specific CD4+ T-cells, IgE and the cytokines IL-4 and IL-5 play central roles in initiating and sustaining an asthmatic response by regulating the recruitment and/or activation of airways ...
Paul S Foster +3 more
doaj +1 more source
The role of interleukin 5 in asthma [PDF]
Expert Review of Clinical Immunology, 2016 Eosinophils were first named in 1879 by Paul Ehrlich, who described their capacity to be stained by eosin, a bright red synthetic dye [1].
Varricchi, Gilda, Canonica, Giorgio W.
openaire +4 more sources
Interleukin-6 level in pediatric patients with COVID-19.
, 2023 Interleukin-6 level in pediatric patients with COVID-19.
Bahrul Fikri (17296062) +8 more
core +1 more source
Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma [PDF]
, 2018 This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of anti-interleukin-13 or anti-interleukin-4 agents, compared with placebo, anti-Immunoglobulin E agents, or anti-interleukin-5 ...
Stewart Drew +15 more
core +3 more sources
, 2003 Interleukin-18 (IL-18), a recently described member of the IL-1 cytokine superfamily, is now recognized as an important regulator of innate and acquired immune responses.
McInnes, I.B. +2 more
core +1 more source
Interleukin-6 levels in the control and AAA groups.
, 2023 There was no significant difference in plasma levels of IL-6 between groups (P = .17). AAA, abdominal aortic aneurysm; IL-6, interleukin-6.
Lenka Maliskova (8781746) +14 more
core +1 more source
Frontiers in Immunology, 2020 Background: Eosinophils develop from CD34+ progenitor cells in the bone marrow under the influence of interleukin (IL)-5. Several cell types produce IL-5, including type 2 innate lymphoid cells (ILC2s).
Emma Boberg +5 more
doaj +1 more source